World
BioNTech to defend against first German lawsuit over COVID-19 vaccine side effects
BioNTech will go to court on Monday to defend itself against a lawsuit from a German woman who is seeking damages for alleged side effects of its COVID-19 vaccine, the first of potentially hundreds of cases in the country.
The woman, exercising her right under German privacy law for her name not to be made public, is suing the German vaccine maker for at least 150,000 euro ($161,500) in damages for bodily harm as well as compensation for unspecified material damage, according to the regional court in Hamburg which is hearing the case and law firm Rogert & Ulbrich, which is representing her.
Read the latest updates in our dedicated coronavirus section.
The plaintiff claims she suffered upper-body pain, swollen extremities, fatigue, and sleeping disorder due to the vaccine.
For the latest headlines, follow our Google News channel online or via the app.
The first hearing is on Monday.
Tobias Ulbrich, a lawyer at Rogert & Ulbrich, told Reuters he aimed to challenge in court the assessment made by European Union regulators and German vaccine assessment bodies that the BioNTech shot has a positive risk-benefit profile.
German pharmaceutical law states that makers of drugs or vaccines are only liable to pay damages for side-effects if “medical science” shows that their products cause disproportionate harm relative to their benefits or if the label information is wrong.
BioNTech, which holds the marketing authorization in Germany for the shot it developed with Pfizer, said it concluded after careful consideration that the case was without merit.
“The positive benefit-risk profile of Comirnaty remains positive and the safety profile has been well characterized,” the biotech firm said, referring to the vaccine’s brand name.
It noted about 1.5 billion people had received the shot across the world, including more than 64 million in Germany.
The European Medicines Agency (EMA) says that BioNTech's Comirnaty, the most commonly used in the Western world, is safe to use.
In a media briefing last week, the EMA reaffirmed the benefit of all COVID-19 shots it approved, including BioNTech's, saying in the first year of the pandemic alone, vaccines were estimated to have helped save almost 20 million lives globally.
It has said there is a very small risk of myocarditis and pericarditis, two types of heart inflammation, following vaccination with Co-mirnaty, mainly for young males.
Unexpected side-effects after a drug has regulatory approval are rare. The unprecedented speed at which COVID vaccines were developed during the pandemic meant that potential uncommon
side-effects may not have been detected as readily as they might have been in traditionally longer trials.
EMA has said that safety monitoring had not been compromised during the fast-track assessment.
The EMA had registered almost 1.7 million spontaneous reports of suspected side-effects by May, which translates into about 0.2 for every 100 administered doses.
Almost 768 million vaccine doses have been administered in the European Economic Area (EEA), which includes the 27 EU member states plus Iceland, Liechtenstein, and Norway.
The most common temporary side-effects are headache, fever, fatigue, and muscle pain.
The EMA also monitors adverse events or illness after vaccination, and checks for frequencies that surpass normal rates in the non-vaccinated population.
Liability
It is not clear who would pay the legal costs or compensation if the plaintiff wins the case.
Sources have said some of the EU's bulk purchase agreements with vaccine makers, including BioNTech-Pfizer, contained full or partial liability waivers for both legal costs and potential
compensation, which could force EU governments to bear some of the costs.
Like many countries, Germany also has a public sector financial support scheme for people who suffer permanent harm from vac-cines, known as a no-fault compensation program, but participa-tion in the program does not block someone seeking damages separately.
The United States has granted manufacturers immunity from liability for COVID vaccines that receive regulatory approval.
Rogert & Ulbrich says it has filed about 250 cases for clients seeking damages for alleged side-effects of COVID-19 vaccines.
Another law firm, Caesar-Preller, says it is representing 100 cases, with both firms saying separately they cover almost all cases in Germany between them.
A handful of similar cases have been filed in Italy.
Read more: Rich countries should play bigger role in fighting pandemics: WHO
Abu Dhabi Overtakes Oslo for Sovereign Wealth Fund Capital in Global SWF’s First City Ranking
Children’s Hospital Los Angeles Named Among Top 10 Children’s Hospitals in the United States 16 Years in a Row
AM Best Briefing in Dubai to Explore State of MENA Insurance Markets; Panel to Feature CEOs From Leading UAE Insurance Companies
-
World3 years agoComprehensive plan for development of Arab culture to be discussed at UAE conference
-
Entertainment2 years ago
R-rated Winnie-the-Pooh movie brings scary spin to Disney’s beloved character
-
World3 years agoHead of new Yemeni council promises end to war via peace process
-
Business1 year agoKuCoin Delivers Keynote Speech at Green Sustainable Finance Forum in COP28 Blue Zone
-
Entertainment7 years agoNew Season 8 Walking Dead trailer flashes forward in time
-
World7 years ago
Illinois’ financial crisis could bring the state to a halt
-
Entertainment7 years ago
The final 6 ‘Game of Thrones’ episodes might feel like a full season
-
Entertainment1 year ago
Hollywood’s video game performers authorize strike if labor talks fail